Cannabis Harm Reduction

Cannabis Harm Reduction is the practical, safety-first companion to the Cannabis reference article in The Library of Ashurbanipal. It covers effects, methods of use, dosing and tolerance, risks, contraindications, drug interactions, testing, and legal/religious context. The aim is plain, non-judgmental, accurate information so that people who use cannabis — legally, medically, or otherwise — can do so more safely, and so that people deciding whether to use it can decide with real facts.

This is education and harm-reduction reference, not medical advice, not a prescription, and not encouragement to use. Cannabis affects individuals very differently; nothing here replaces a clinician who knows your history. For the plant, its history, and its pharmacology, see Cannabis.

Effects

Cannabis effects depend on the chemical profile (THC, CBD, and terpene mix — see the entourage effect), the dose, the method, the person, and the setting. Two products with the same THC number can feel very different.

Commonly reported short-term effects:

Euphoria, relaxation, altered perception of time, heightened senses, increased appetite ("the munchies").
Sedation and "couch-lock" (associated with high-myrcene varieties), or alertness and focus (associated with high-limonene/pinene varieties).
Dry mouth, red eyes, increased heart rate, and slowed reaction time and coordination.
Short-term memory and attention effects while intoxicated.

Common adverse short-term effects, especially at higher doses or in less experienced users:

Anxiety, paranoia, or panic — one of the most common bad reactions, more likely with high-THC/low-CBD products and large doses.
Dizziness, nausea, and — with very large edible doses — a "green-out" (intense discomfort, vomiting, disorientation). Unpleasant but, for cannabis alone, not known to be directly fatal.
Rarely, acute confusion or transient psychotic symptoms at very high doses.

Methods of use

Method changes onset, duration, and intensity — the single most important thing to understand for dosing safely:

Inhalation (smoking, vaporizing). Onset in seconds to minutes; peak within ~10–30 minutes; largely worn off in 1–3 hours. Fast onset makes it easier to "titrate" (take a little, wait, judge). Smoking combusts plant material and produces tar and irritants; vaporizing heats without full combustion and is generally considered less harsh on the lungs (see risks).
Oral (edibles, capsules, tinctures swallowed). Onset delayed 30 minutes to 2 hours — sometimes longer on a full stomach — with effects lasting 4–8 hours or more. The liver converts THC to 11-hydroxy-THC, often more potent and longer-lasting. The delayed onset is the classic cause of over-consumption: people take more before the first dose lands. Start low, go slow, and wait a full 2 hours before re-dosing.
Sublingual (tinctures held under the tongue). Faster than swallowed edibles, easier to dose in small increments.
Topicals. Applied to skin for localized effect; generally non-intoxicating.

Dosing and tolerance

There is no single "correct" dose — it depends on the person, product, and goal. General harm-reduction guidance:

"Start low, go slow." For edibles, a common low starting dose is 2.5–5 mg THC, waiting a full 2 hours before considering more. Many commercial products are far stronger per piece than they look. (Dose ranges are general references from public health and cannabis-education sources, not a prescription; individual sensitivity varies widely.)
You cannot un-take an edible. Because oral onset is slow and long, over-dosing on edibles is easy and the discomfort lasts hours.
Tolerance builds with regular use — regular users need more for the same effect. A tolerance break (a period of abstinence) restores sensitivity.
CBD can temper THC. Products with meaningful CBD alongside THC are often reported as less anxiety-provoking than pure high-THC products, consistent with the entourage-effect framework.
If someone greens out: keep them calm, seated or lying safely, hydrated, and reassured that it passes. CBD, black pepper (which contains β-caryophyllene), and rest are commonly used comfort measures. Seek medical help if breathing is affected, the person can't be roused, or another substance may be involved.

Risks

Honest accounting, marking what is well-established versus uncertain:

Dependence. Cannabis use disorder is real; roughly 1 in 10 users develop some dependence, with higher risk for those who start young or use daily (established, CDC/NIDA estimates). Withdrawal (irritability, sleep trouble, appetite loss) is real but not life-threatening.
Adolescent brain. Regular heavy use during adolescence is associated with lasting cognitive effects, because the brain is still developing (established association; exact magnitude debated).
Mental health / psychosis. Heavy, high-potency use is associated with increased risk of psychosis and may trigger or worsen it in people predisposed (e.g. family history of schizophrenia). Whether cannabis causes psychosis versus unmasks/accelerates it in the vulnerable is still debated — but the risk signal is strong enough that people with personal or family history of psychotic illness should be especially cautious.
Lungs. Smoking anything irritates the airways and can cause chronic bronchitis-type symptoms; cannabis smoke contains many of the same irritants and carcinogens as tobacco smoke. A clear independent link between cannabis smoking and lung cancer is less established than for tobacco, partly because most studies involve people who also smoke tobacco. Vaporizing and non-inhaled routes avoid combustion. (Note: illicit-market vape cartridges cut with vitamin E acetate caused the 2019 "EVALI" lung-injury outbreak — a contaminant issue, see testing.)
Cardiovascular. THC raises heart rate and can transiently raise blood pressure; caution for people with heart disease.
Cannabinoid hyperemesis syndrome (CHS). Long-term heavy users can develop cycles of severe vomiting, often oddly relieved by hot showers; it resolves with cessation (established but under-recognized).
Impairment. Driving or operating machinery while impaired is dangerous and illegal; impairment can outlast the subjective "high," especially with edibles.
Pregnancy and breastfeeding. Cannabinoids cross the placenta and enter breast milk; use during pregnancy/breastfeeding is generally advised against.

Contraindications

Situations where caution or avoidance is especially warranted:

Personal or family history of psychosis, schizophrenia, or bipolar disorder — high-THC cannabis can precipitate or worsen episodes.
Pregnancy or breastfeeding.
Adolescence — developing brain.
Serious cardiovascular disease — due to heart-rate and blood-pressure effects.
History of cannabis use disorder or CHS.
Concurrent use of sedatives, alcohol, or other CNS depressants — additive impairment (see interactions).

Drug interactions

Cannabinoids, especially CBD, can meaningfully affect how other drugs are metabolized. This section flags the categories that matter — always check with a pharmacist or clinician for your specific medications:

CYP450 enzyme interactions. CBD (and to a lesser extent THC) inhibits liver enzymes CYP3A4 and CYP2C19, which metabolize a large fraction of prescription drugs. Inhibiting them can raise blood levels of those drugs. This is well-established for CBD.
The "grapefruit rule." A practical shortcut: if a medication's label warns against grapefruit juice, treat cannabis/CBD with the same caution — grapefruit inhibits the same CYP3A4 pathway.
Blood thinners (e.g. warfarin) — cannabis/CBD can raise levels and bleeding risk; requires monitoring.
Anticonvulsants — CBD interacts notably with clobazam and others (documented in epilepsy trials of pharmaceutical CBD).
CNS depressants — alcohol, benzodiazepines, opioids, and sleep aids have additive sedation and impairment with cannabis; combining them increases the risk of over-sedation.
Other psychoactives. Combining cannabis with other drugs (including kava's yangonin discussed under the endocannabinoid system, or psychedelics) compounds unpredictability; when in doubt, don't stack.

(Interaction information here is general reference; it is not a complete list. Bring up cannabis with the professional managing your medications.)

Testing and quality

Because potency and contaminants vary — and illicit-market products are unregulated — testing matters:

Potency labeling. Regulated-market products are lab-tested for THC/CBD content; this is the only reliable way to dose an edible. Treat unlabeled products as unknown strength.
Contaminant testing. Reputable labs screen for pesticides, heavy metals, residual solvents, mold, and microbial contamination. Poorly grown or stored cannabis can carry mold (e.g. Aspergillus), a real risk for immunocompromised people.
Adulterants in illicit products. The 2019 EVALI lung-injury outbreak was traced to vitamin E acetate cut into illicit-market THC vape cartridges — a stark example of why unregulated concentrates carry contaminant risk. Fentanyl contamination of cannabis flower is widely rumored but has been rare and mostly unconfirmed; the greater documented risk is with counterfeit pills, not flower. Drug-checking / reagent services exist in some regions for people who want to verify what they have.
Storage. Store cannabis cool, dark, and dry to limit mold and slow degradation (THC slowly converts to sedating CBN as it ages).

Legal and religious context

Cannabis law is a patchwork and changes constantly — this is orientation, not legal advice:

United States. Cannabis remains federally a Schedule I controlled substance, while many states have legalized medical and/or adult recreational use. Federal and state law can conflict; a proposed rescheduling to Schedule III has been under review. Hemp (under 0.3% THC) was federally legalized by the 2018 Farm Bill.
Internationally. Regimes range from full legalization (e.g. Canada, Uruguay) to decriminalization to severe criminal penalties. Penalties in some countries are extremely harsh — know the law where you are.
Medical programs. Many jurisdictions have medical-cannabis programs with their own eligibility, possession, and physician-recommendation rules.
Religious and traditional use. Cannabis has a long sacramental history — bhang in Hindu tradition, use among the Rastafari movement, and others. Some jurisdictions recognize limited religious-use exemptions, but such exemptions are narrow, contested, and vary widely; a sincere religious claim does not guarantee legal protection. This connects to the Library's broader interest in the religious and legal frameworks around traditional plant use.

Bottom line

Know your chemical profile, not just the strain name (see terpenes and cannabinoids).
Start low, go slow — especially with edibles, and wait a full 2 hours.
Check the grapefruit rule against your medications, and ask a pharmacist.
Be honest about personal/family psychosis history, pregnancy, adolescence, and heart disease as real contraindications.
Prefer tested product; treat unlabeled and illicit concentrates as unknown.
Know the law where you are.

Sources

Van Kush Family Research Institute, Comprehensive Marijuana Education Guide (January 2026) — plant and pharmacology context.
U.S. Centers for Disease Control and Prevention (CDC) and National Institute on Drug Abuse (NIDA) — cannabis health-effects and dependence data.
Russo, E.B. (2011). "Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects." British Journal of Pharmacology 163(7), 1344–1364.
Brown, J.D. & Winterstein, A.G. (2019). "Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use." Journal of Clinical Medicine 8(7), 989.
U.S. FDA / CDC reporting on EVALI and vitamin E acetate (2019–2020).